New patent expiration for King Pharms drug SKELAXIN

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SKELAXIN
Annual Drug Patent Expirations for SKELAXIN

Skelaxin is a drug marketed by King Pharms and is included in one NDA. It is available from four suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

SKELAXIN drug price trends.

Drug patent litigation for SKELAXIN.

This drug has two patent family members in two countries.

The generic ingredient in SKELAXIN is metaxalone. Four suppliers are listed for this compound. Additional details are available on the metaxalone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top